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SCHEENEN, W. J. J. M., H. G. YNTEMA, P. H. G. M. WILLEMS, E. W. ROUBOS, I  R. LIESTE AND B. G. JENKS. 
Neuropeptide Y inhibits Ca2+ oscillations, cyclic AMP, and secretion in melanotrope cells of Xenopus laevis via a Y\ receptor, 
PEPTIDES 16(5) 889-895, 1995.— The melanotrope cells in the pituitary gland of Xenopus laevis are innervated by neurons 
containing neuropeptide Y (NPY). In the present study, the mechanism of action of NPY on the melanotropes has been investigated.
NPY inhibited in vitro secretion from melanotropes in intact neurointermediate lobes as well as from isolated, single melanotropes. 
Inhibition of secretion from neurointermediate lobes was mimicked by the NPY analogues PYY and [Leu3l,Pro34]NPY, whereas 
NPY(13-36) was inactive. Secretion from isolated melanotropes was inhibited by [Leu31,Pro34]NPY and NPY(13-36), but 
NPY(13-36) was 10-fold less potent than [Leu3\Pro34]NPY. Studies on isolated cells revealed that NPY and its analogues inhibited 
the occurrence of intracellular Ca2+ oscillations with the same potency as they inhibited secretion from isolated cells. In addition 
to inhibiting basal secretion and spontaneous Ca2+ oscillations, NPY inhibited the basal production of cyclic AMP. On the basis 
of these results it is proposed that NPY inhibits secretion from Xenopus melanotropes by inhibiting cyclic AMP-dependent 
spontaneous Ca2+ oscillations through a Y r like receptor.
Neuropeptide Y Melanotrope cells Xenopus laevis Ca2+ oscillations Cyclic AMP
MELANOTROPE cells in the pars intermedia of the pituitary 
gland of the amphibian Xenopus laevis convert neural input by 
classical neurotransmitters and neuropeptides into a hormonal 
output, viz. the secretion of a-melanophore-stimulating hormone 
(a-MSH). This hormone causes dispersion of pigment in dermal 
melanophores resulting in darkening of the skin (14,15), Re­
cently, particular attention has been paid to the cellular signaling 
mechanisms that transduce the neural inputs into a-MSH secre­
tion. Corticotropin-releasing hormone (CRH) stimulates a-MSH 
secretion by stimulating adenylyl cyclase (8), whereas thyrotro­
pin-releasing hormone (TRH) stimulates this secretion by 
enhancing the production of inositol trisphosphate (11). On the 
other hand, melanotropes also receive various inhibitory inputs. 
It has been shown that ,y-aminobutyric acid (GABA) inhibits a- 
MSH secretion via two receptor subtypes, a chloride channel 
containing a GABAa receptor, and a G-protein-coupled GABAb 
receptor that inhibits adenylyl cyclase (8,15). Dopamine inhibi­
tion of a-MSH secretion is achieved via a D2-like receptor cou­
pled to a G-protein and inhibiting adenylyl cyclase (8,15). The 
present study is concerned with the cellular signal transduction 
pathway by which neuropeptide Y (NPY) inhibits a-MSH secre­
1 Requests for reprints should be addressed to Bruce G. Jenks, Department of Animal Physiology, Nijmegen Institute for Neurosciences, University 
of Nijmegen, Toemooiveld 1, 6525 ED Nijmegen, The Netherlands.
tion. The inhibitory effect of NPY is very characteristic as it lasts 
for many hours after removal of NPY, in contrast to the short- 
lasting inhibitions evoked by GAB A and dopamine (17). Recent 
studies have revealed that NPY is also a very potent blocker of 
spontaneously occurring intracellular Ca2+ oscillations in isolated 
Xenopus melanotropes kept in vitro (25,27). Several studies in 
central and peripheral tissues indicate that NPY acts in both 
mammals and nonmammals (6,18,22), generally acting via in­
hibition of adenylyl cyclase activity (1,18,19,29,34). For Xeno­
pus melanotropes it was found that spontaneous Ca2+ oscillations 
depend on Ca2+ influx through cj-conotoxin-sensitive Ca2+ chan­
nels (24,28). Furthermore, inhibition of the cAMP-dependent 
protein kinase led to an inhibition of Ca2+ oscillations (27). 
Therefore, in the present study we have investigated the possi­
bility that NPY inhibits a-MSH secretion from Xenopus melan­
otropes by binding to a specific receptor that inhibits cAMP pro­
duction and occurrence of the Ca2+ oscillations.
First, the NPY receptor subtype involved in inhibition of a- 
MSH secretion was identified. At least three receptor subtypes 
have been described for NPY, as reviewed by Michell (18). The 
subtypes can be distinguished on the basis of their differential
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responses to agonistic NPY analogues; the Yj receptor subtype 
is activated by [Leu31,Pro34]NPY but not by NPY(13~36), 
whereas, conversely, the Y2 receptor subtype is activated by 
NPY(13-36) but not by [Leu31 ,Pro34]NP Y (3,18). Peptide YY 
(PYY) activates both the Yi and the Y2 receptors but has no effect 
on the Y3 receptor (18). To determine the receptor subtype that 
is responsible for the inhibitory action of NPY on Xenopus me- 
lanotropes, the effects of NPY and NPY analogues on a-MSH 
secretion from superfused neurointermediate lobes were studied. 
Furthermore, to substantiate the hypothesized relation between 
spontaneous Ca2+ oscillations and hormone secretion (25,27), the 
effects of NPY and the analogues on oscillations and secretion 
were investigated with in vitro superfusion and dynamic video 
imaging techniques, using isolated, single melanotropes. Finally, 
the possible involvement of cAMP in NPY-induced inhibition of 
a-MSH secretion was tested by determining the effects of a 
membrane permeable cAMP analogue on spontaneous Ca2+ os­
cillations, and by measuring cAMP release from neurointerme­
diate lobes.
METHOD
Animals
Young adult Xenopus laevis were taken from laboratory stock 
and adapted to a black background for 3 weeks under continuous 
illumination, at 22°C. They were fed weekly with beef heart.
In Vitro Secretion Studies With Neurointermediate Lobes
Neurointermediate lobes were rapidly dissected and placed in 
10-/xl superfusion chambers. Four chambers were superfused si­
multaneously with incubation medium (IM) consisting of 112 
mM NaCl, 2 mM  KC1, 2 mM CaCl2, 15 mM Ultral-HEPES (pH 
7.4; Calbiochem, La Jolla CA), 2 mg/ml glucose, 0.3 mg/ml bo­
vine serum albumin (Sigma, St. Louis MO), and 1 /¿g/ml ascorbic 
acid, at a rate of 1.5 ml/h, at 22°C. To establish stable release, 
lobes were superfused for at least 75 min (10 fractions of 7.5 
min) with IM before NPY and its analogues were added. The 
concentration of cv-MSH in each fraction was determined by ra­
dioimmunoassay (31). Basal (spontaneous) a-MSH release was 
defined as the average secretion in the three fractions preceding 
the first application. Details on concentrations of the NPY ana­
logues used and their administration protocols are given in the 
results section. In experiments in which cAMP secretion was 
measured, superfusion was performed in the presence of 0.1 mM 
3-isobutyl-1-methylxanthine (IBMX, Sigma) and fractions were 
collected every 15 min (8).
Preparation of Single Melanotropes
Isolation of melanotrope cells was performed as described 
previously (24). In short, after anesthetization in 0.1% MS222 
(Sigma) animals were perfused with Xenopus Ringer’s solution, 
containing 112 mM NaCl, 2 mM KC1,2 mM CaCl2, and 15 mM 
Ultral-HEPES, to remove blood cells. Then neurointermediate 
lobes were dissected and incubated for 45 min in Ringer’s so­
lution without CaCl2 to which 0.25% (w/v) trypsin (Gibco, Ren­
frewshire, UK) had been added. Cells were subsequently dis­
persed in Leibovitz's L15 medium, which had been adjusted to 
Xenopus blood osmolality (L15:ultrapure water, 2:1) and con­
tained 10% fetal calf serum (Gibco). Single cells were plated on 
glass cover slips coated with poly~L-lysine (Sigma; mol.wt. > 
300 JcDa) at a density of 10,000 cells/slip. At least 95% of the 
cells prepared in this way are melanotropes (9).
Measurement of Peptide Release From Single Melanotropes
To measure secretion from single cells, freshly isolated cells 
were cultured in 75 y\ IM containing 22.5 fiCi [3H]lysine (86 Ci/ 
mmol; Amersham, Buckinghamshire, UK) for 18 h. After wash­
ing, coverslips were placed in a superfusion chamber with a vol­
ume of 200 //l. The superfusion flow rate was 1 ml/min. Cells 
were superfused for 1.5 h before NPY analogues were added and 
1 -min fractions were collected. To each fraction 1 ml scintillation 
fluid (Optiphase ‘HiSafe’ 3, LKB-Wallac, Turku, Finland) was 
added and radioactivity was determined using a /?-counter (1216 
Rackbeta, LKB-Wallac).
Radioimmun oassays
Radioimmunoassay for a-MSH was performed as described 
previously, using an antiserum raised in our laboratory (31), 
which has equal affinity for the acetylated and nonacetylated 
forms of a-MSH. Cross-reactivities with ACTH(l-24) and 
ACTH(l-39) were below 0.01%. Bound and free antibodies 
were separated by polyethylene glycol/ovalbumin precipitation. 
Detection limit was 2 pg a-MSH per sample. Superfusion frac­
tions were assayed in duplicate. Radioimmunoassay for cAMP 
was performed as described previously (8), using a cAMP-RIA 
kit from Amersham. Detection limit was 1 fmol cAMP per 
sample.
Ca2+ Measurements
Ca2+ measurements in isolated melanotrope cells were per­
formed as described previously (24,25). In short, single cells 
were cultured for three days at 22°C. After culturing, cells were 
loaded with 2 pM Fura-2/AM (Molecular Probes, Eugene, OR) 
in IM containing 1 \xM pluronic FI27 (23) (Molecular Probes) 
for 20 min at 22°C. After loading, cells were washed with IM in 
a Leiden perifusion chamber (13) (volume 800 ¡A) at a rate of 1 
ml/min, for 25 min. During this wash unattached cells were 
sucked off and attached cells were allowed to equilibrate. The 
chamber was placed on the stage of an inverted microscope (Ni­
kon Diaphot, Tokyo, Japan) and the light from a 100-W xenon 
lamp was directed through a quartz neutral density filter (ND 2, 
Ealing Electro-Optics, Holliston, MA) to reduce bleaching of the 
intracellularly trapped fluorochrome. The excitation bandpass fil­
ters, mounted in a motor-driven rotating wheel, had transmission 
maxima at 340 and 380 nm (± 12 nm) (Ealing Electro-Optics). 
The fluorescence emission ratio at 492 nm was used as a measure 
of [Ca2+]? after excitation at 340 and 380 nm (21). An epiflu- 
orescent 40X magnification oil immersion objective was used. 
Dynamic video imaging was carried out using the MagiCal hard­
ware and TARDIS software of Joyce Loebl (Dukesway, Tyne & 
Wear, UK) as described by Neylon et al. (20). The interframe 
interval between the ratio frames was 6.4 s with a maximal sam­
pling time of 32 min. Test substances were added to the bath 
using a perifusion pump.
Compounds
Substances tested were NPY, NPY(13-36), PYY (Bachem Fein- 
chemikalien AG, Bubendorf, Switzerland), and [Leu31,Pro34]NPY 
(Bachem California, Torrance, CA). 8-Br-cAMP was obtained 
from Sigma. In some experiments a test-pulse of dopamine 
(Sigma) was included.
Calculations and Statistics
Results of superfusion experiments with neurointermediate 
lobes are shown as the average ± SEM of four lobes superfused
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FIG. I . Dose-response relationship of NPY analogues on a-MSH se­
cretion from neurointermediate lobes. The efficacies of PYY and NPY 
were similar; both analogues produced a maximal inhibition of 60% at 
1 ¡xM, [Leu‘1i,ProM]NPY was less potent that NPY and PYY at 0.1 and
1 /iM , but eventually reached a similar efficacy at 3.3 pM. NPY(J3-36) 
did not inhibit a-MSH secretion at any concentration tested. At 3.3 and
10 pM NPY(13-36) caused a stimulation of 16%.
in one experiment, unless stated otherwise. Each experiment was 
performed at least two times independently. Percentages of in­
hibition and stimulation of a-MSH or cAMP release were cal­
culated on the basis of integration of the respective peak areas in 
the graphs, using three fractions preceding and three fractions 
following the onset of experimental treatment. In superfusion ex­
periments with isolated melanotropes, pulses of 5 min were given 
(five fractions), and the inhibition was calculated using the five 
fractions before and the five fractions after the onset of treatment. 
The graph of a representative experiment is shown. Each exper­
iment was performed at least two times independently. The in­
tegrated areas were analyzed with the paired Student’s f-test. A 
value of p < 0,05 was considered to indicate statistical signifi­
cance.
For Ca2* imaging representative profiles of single cells are 
given. Each experiment was conducted a minimum of three 
times. The total number of cells examined for each treatment is 
given in the Results section, as is the total number of cells that 
gave a response.
RESULTS
Effects of NPY and NPY Analogues on a-MSH Secretion From 
Neurointermediate Lobes
NPY dose-dependently inhibited basal a-MSH secretion with a 
minimum effective concentration of 0.1 pM> leading to an inhibition 
of 12 ± 8%. Maximum inhibition (60 ±7%) was achieved at a 
concentration of 1 pM (Fig, 1). PYY was slightly more potent than 
NPY in inhibiting a-MSH secretion, giving 33 ± 3% inhibition at
a concentration of 0.1 ¡iM (Fig. 1). Although the efficacy, achieved 
over a period of 22.5 min, was similar for NPY and PYY, the 
recovery from inhibition clearly differed; NPY had a long-lasting 
effect (more than 1 h), whereas PYY-induced inhibition fully dis­
appeared within 37.5 min following PYY removal (five superfusion 
fractions) (Fig. 2). [Leu31,Pro34]NPY inhibited a-MSH secretion at 
a minimal effective concentration of 0.1 pM, giving 1.0 ± 6% in­
hibition, and maximum inhibition (60 ± 7%) was achieved at a 
concentration of 3.3 pM (Fig. 1). NPY(13-36) was ineffective in 
inhibiting a-MSH secretion in concentrations up to 10 pM (Fig. 1).
Effects of NPY and NPY Analogues on Secretion From Single 
Cells
During a 5-min pulse NPY inhibited release of radioactive 
peptides from single cells cultured on coated coverslips by 50% 
when applied at a concentration of 1 nM [Fig. 3(A)]. At 10 nM 
the percentage of inhibition was 60%. Compared to the dopa­
mine-induced inhibition, recovery from inhibition with NPY was 
long lasting after removal of the inhibitor. Both NPY analogues 
inhibited secretion; after removal of the inhibitor the inhibition 
by [Leu3\Pro34]NPY was readily reversible whereas the effect of 
NPY(13-36) was long-lasting. At 1 nM [Leu31,Pro34]NPY inhib­
ited secretion by 45% [Fig. 3(B)]; when a concentration of 10 
nM was given maximum inhibition was reached (55%) [Fig. 
3(B)]. NPY( 13-36) at 1 nM had no effect on secretion; 10 nM 
inhibited secretion by 35%; and 100 nM NPY(13~36) induced 
an inhibition of 50% [Fig, 3(C)].
Effects of NPY and NPY Analogues on Spontaneous Ca2+ 
Oscillations in Single Melanotropes
Both NPY and PYY appeared to be very potent in blocking 
spontaneous Ca2+ oscillations in single melanotropes. Complete 
inhibition in all cells by NPY was reached at a concentration of 
1 nM [Fig. 4(A), N = 29]. PYY was similarly effective in inhib­
iting the spontaneous Ca2+ oscillations, causing a complete in­
hibition at 1 nM [Fig. 4(B), N - 11]. [Leu31,Pro34]NPY com­
pletely inhibited spontaneous Ca2+ oscillations at a concentration 
of 10 nM [Fig. 4(C), N — 18], whereas in 4 of the 18 cells os­
cillations were already blocked at 1 nM, NPY(13-36) inhibited 
oscillations in 5 out of 13 cells when tested at a concentration of
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FIG. 2. Reversibility of PYY- and NPY-induced inhibition of a-MSH 
secretion in freshly dissected neurointermediate lobes. The PYY-induced 
inhibition was completely reversed within five superfusion fractions 
(37.5 min) after removal of the test substance. NPY-induced inhibition 
was only reversed by 45% after nine superfusion fractions (67.5 min).
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FIG. 3. Effect of dopamine and NPY, [Leu3l,Pro34]NPY and NPY(13- 
36) on radioactive peptide release from single melanotropes. (A) Do­
pamine and NPY inhibit secretion from isolated melanotropes. Dopa­
mine (10 nM) inhibition was reversed 6 min after dopamine removal; 
removal of 10 nAf NPY caused a very slow reversal of the inhibition, 
which was not completed after 30 min. (B) Dose-response relationship 
of [Leu3\Pro34]NPY-induced inhibition: 1 nAf caused an inhibition of 
45%; maximum inhibition (55%) was reached at 10 nAf; application of 
100 nM did not increase the magnitude of the inhibition but caused a 
long-lasting inhibition. (C) Dose-responserelationship of NPY(13-36): 
1 nM did not inhibit secretion; 10 nAf resulted in an inhibition of 35%; 
and 100 nM caused a long-lasting inhibition of 50%.
10 nM. Complete inhibition of the oscillations in all cells was 
achieved by 100 nMNPY(13-36) [Fig. 4(D), N = 13].
Effect of 8-Br-cAMP on Ca2+ Oscillations in Single 
Melanotropes
The cell-permeable cAMP analogue 8-Br-cAMP increased 
the frequency of spontaneous Ca2+ oscillations by 134 ± 12% 
when applied at 1 mM [Fig. 5(A), N = 33]. 8-Br-cAMP at 1 mM 
induced oscillations in six out of eight nonoscillating cells [Fig. 
5(B)]. Under NPY-inhibited conditions (1 nM), 8-Br-cAMP in­
duced Ca2+ oscillations in 35 out of 41 cells [Fig. 5(C)].
Effect of NPY on cAMP Release From Neurointermediate 
Lobes
When 1 fjM NPY was added to the superfusion medium in 
the presence of IBMX, a-MSH secretion was reduced by 60 ± 
5%. Parallel to this inhibition, an inhibition of cAMP secretion 
of 55 ± 13% was found (Fig. 6). In the same experiment, a pulse 
of dopamine was given as this is known to exert a well-charac- 
terized effect on cAMP production (8). Dopamine produced 55 
± 8% inhibition of a-MSH secretion and 40 ± 6% inhibition of
cAMP secretion. The dopamine-induced inhibition had fully dis­
appeared within 30 min following dopamine removal (two su- 
perfusion fractions), whereas the inhibition of NPY was long- 
lasting: even after 1 h (four superfusion fractions) the release of 
a-MSH and cAMP had not returned to basal levels.
DISCUSSION
In the present study, we investigated the action mechanism 
by which NPY inhibits secretory activity of Xenopus melano­
tropes. The finding that NPY is a blocker of secretion from mela­
notropes in neurointermediate lobes is consistent with earlier 
studies (32). From the studies on the action of NPY analogues 
on a-MSH secretion from neurointermediate lobes, showing that 
NPY, PYY, and [Leu31,Pro34]NPY inhibit secretion whereas 
NPY(13-36) does not, we conclude that a Y r like receptor sub- 
type is involved. The finding that PYY is slightly more potent
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FIG. 4. Effects of NPY, PYY, and [Leu31,Pro34]NPY on spontaneous 
Ca2+ oscillations. (A) NPY inhibits spontaneous oscillations in all cells 
studied at a concentration of 1 nAf. (B) PYY inhibits the oscillations in 
all cells at 1 nAf. (C) [Leu3l,Pro34]NPY inhibits the oscillations in 22% 
of the cells at 1 nAf. To achieve an inhibition in all cells a concentration 
of 10 nAf had to be applied. (D) NPY(13-36) inhibits oscillations in all 
cells at a concentration of 100 nAf. At 10 nAf oscillations were blocked 
in 5 out of 13 cells.
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FIG. 5. Effects of 8-Br-cAMP on Ca2* oscillations. (A) 8-Br-cAMP (1 
mM) strongly increased the frequency of spontaneous oscillations 
(120%). (B) In six out of eight nonoscillating cells 1 mM 8 -Br-cAMP 
induced oscillations. (C) 1 mAi 8-Br-cAMP reversed the 1 nM NPY- 
induccd inhibition of Ca2 1 oscillations.
than NPY and [Leu^Pro^NPY is slightly less potent than NPY 
is in agreement with the different potencies of these analogues 
to Ypreceptors reported in other studies (3,18).
NPY acts with a long duration on Xenopus melanotropes as 
is clear from the fact that the recovery from inhibition by neu- 
rointermediate lobes and single melanotropes is slow. This action 
seems to be specific for NPY as it was not displayed by PYY, 
The most likely explanation for this phenomenon is that the bind­
ing of NPY to its receptor is less reversible than that of PYY.
The pharmacological characteristics of the NPY receptor re­
sponses found in our secretory studies with cultured melanotro- 
pes differed from the strict Y t classification found for freshly 
dissected neurointermediate lobes. Although the Yi receptor ag­
onist [Leu3I,ProM]NPY was effective both in fresh tissue and 
cultured single melanotropes, the cultured cells also showed an 
inhibitory secretory response to NPY( 13-36), a NPY analogue 
that specifically activates a Y2 receptor subtype. In other tissues, 
a 100- to 1000-fold difference in potency between these Y| and 
Y2 receptor agonists for the Yi receptor has been reported (3,18), 
The fact that, in our experiments with cultured Xenopus melan­
otropes, only a 10-fold difference was found might indicate that 
with culturing there is induction of a Y2 receptor. Alternatively, 
the results could reflect changes in Yi receptor structure as a 
result of cell culture and/or trypsinization. Changes in receptor 
structure after trypsinization and subsequent changes in receptor 
affinity for ligands have been reported for IgG receptors in mono­
cytes (30). Because the Yi receptor agonist is more potent than 
the Y2 receptor agonist and because for fresh lobes no Y2 effect 
was found, we conclude that a Yrlike receptor is primarily in­
volved in the inhibition of ar-MSH secretion in vivo. We further 
suggest that the Y2 receptor agonist activity, seen in the present 
study and also reported by Kongsamut et al. (16), reflects an
artifact.
It was apparent that the secretory activity of cells cultured oil 
poly-L-lysine-coated coverslips was 100 times more sensitive to 
the inhibitory action of NPY and its analogues than that of the 
freshly dissected tissue. Possible explanations for this phenom­
enon are: 1) an increase in density of receptors on cultured cells, 
and 2) a relatively poor accessibility of the melanotropes in intact 
lobes for exogenously applied NPY, This accessibility could be 
hampered by, for instance, a relatively poor penetration of NPY 
into the tissue, the uptake of NPY by glial cells, or extracellular 
enzymatic degradation of NPY. It should be noted that in vivo 
NPY reaches the melanotrope via specialized local synaptic con­
tacts so that the peptide may locally reach relatively high con­
centrations (10).
Testing NPY and its analogues on intracellular Ca24* dynamics 
showed that NPY as well as analogues are capable of completely 
inhibiting spontaneous Ca2+ oscillations. In secretion studies 
with isolated melanotropes, NPY induced only 60-70% inhibi­
tion of basal secretion of radiolabeled products, which seems to 
be contradictory to the complete inhibition of Ca2+ oscillations 
by NPY in such cells. However, in recent studies we found that 
about one-third of radiolabeled products released by the single 
melanotropes consists of amino acids not incorporated into pep­
tides (Jenks, unpublished observation). Therefore, we propose 
that NPY is able to inhibit completely both peptide secretion and 
Ca2+ oscillations.
In Ca2+ measurements, the Yi agonist was more potent than 
the Y2 agonist in inhibiting the occurrence of spontaneous Ca2+ 
oscillations. The observation that the potency of the NPY ana­
logues was equal for inhibiting single cell secretion and Ca2+
oscillations supports earlier arguments that spontaneous Ca os­
cillations are the driving force for in vitro a-MSH secretion 
(25,27).
NPY receptors have been demonstrated to inhibit the adenylyl 
cyclase system in various cell types (1,18,19,29,34), but there are 
also reports that Y{ receptor activation can lead to an increase in 
intracellular (Ca2+) (1,7,29,33) and that the Y2 receptor directly 
inhibits a (N-type) voltage-operated Ca2+ channel (2,4,5,12,33). 
To assess whether NPY receptor activation in Xenopus melano­
tropes leads to a decreased cAMP production, we investigated 
the effect of NPY on cAMP efflux. This efflux can be taken as
FIG, 6 , Comparison of dopamine- and NPY-induced inhibition of the ex- 
MSH secretion (A) and cAMP release (B) in neurointermediate lobes. A 
strong correlation between inhibition of «-MSH secretion and inhibition 
of cAMP efflux was noted for both factors.
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a measure for the intracellular cAMP concentration (8). The re­
sults show that NPY decreases cAMP efflux from Xenopus me­
lanotropes, indicating that NPY inhibits the production of cAMP. 
This finding is in agreement with the action of NPY in most cell 
systems studied.
For Xenopus melanotropes, it has been reported that inhibition 
of cAMP-dependent protein kinase leads to an abolishment of 
spontaneous Ca2+ oscillations (26). Our data, showing that a cell- 
permeable cAMP analogue can increase the frequency of spon­
taneously occurring Ca2+ oscillations and can induce oscillations 
in nonoscillating cells [see also (26)], support the idea that in 
Xenopus melanotropes a cAMP-dependent phosphorylation is in­
volved in the induction of spontaneous Ca2+ oscillations. The 
observation that 8-Br-cAMP could reverse NPY-induced inhi­
bition of Ca2+ oscillations is consistent with the conclusion that
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